Skip to content
Disclosery

ORBIMED ADVISORS LLC: JANX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on JANX, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 524,700 JANX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 524,700 shares
    Change vs previous 13F -458,900 shares

    0.15% of the 13F portfolio, value $8,059,392.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 983,600 shares
    Change vs previous 13F -970,826 shares

    0.3% of the 13F portfolio, value $13,672,040.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,954,426 shares
    Change vs previous 13F +188,326 shares

    0.55% of the 13F portfolio, value $26,971,079.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,766,100 shares
    Change vs previous 13F +555,800 shares

    1.04% of the 13F portfolio, value $43,163,484.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,210,300 shares
    Change vs previous 13F +451,734 shares

    0.7% of the 13F portfolio, value $27,957,930.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 758,566 shares
    Change vs previous 13F 0 shares

    0.49% of the 13F portfolio, value $20,481,282.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 758,566 shares
    Change vs previous 13F -500,000 shares

    0.84% of the 13F portfolio, value $40,613,624.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 1,258,566 shares
    Change vs previous 13F not available

    1.05% of the 13F portfolio, value $57,176,653.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).